BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma
- Type
- Retraction
- Notice date
- 2/23/2018 0:00
- Journal
- Biochemical and Biophysical Research Communications (BBRC)
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.bbrc.2018.03.006
- Original paper DOI
- 10.1016/j.bbrc.2017.07.139